Vaxart Inc

-0.37 (-6.98%)
Earnings Announcements

Vaxart Reports Positive Hamster Study Data For Oral Covid-19 Vaccine

Published: 10/14/2020 12:18 GMT
Vaxart Inc (VXRT) - Vaxart Announces Positive Hamster Challenge Study Data for Its Oral Covid-19 Vaccine.
Vaxart Inc - Available Results Show That All Hamsters That Received Two Oral Doses of Covid-19 Vaccine Candidate Showed No Systemic Weight Loss.
Vaxart Inc - All Animals Vaccinated With Two Doses of Oral Vaccine Maintained Or Gained Body Weight by End of Experiment.
Vaxart Inc - Animals in Study Were Protected Against Lung Weight Gain Seen in Unvaccinated Animals.
Revenue is expected to be $1.07 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $2.9 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.